Film manufacturing company Perlen Packaging is investing more than Sfr20m ($20.3m) in the expansion of its PVdC coating line capacity in Perlen, Switzerland, to increase the coating capacity.

The company has also started construction on a production facility at Wujiang, China, which is expected to become operational next year.

Perlen Packaging CEO Wolfgang Grimm said: "The Asian pharmaceutical markets are showing double-digit growth rates. As the first foreign company to set up a production facility in China, Perlen Packaging’s aim is to cater to the expected growth in the region and to better serve the markets from a local site."

"We can ensure the continued availability of our high-quality products for the European pharmaceutical market."

Based in Switzerland, Perlen Packaging is a unit of industrial group CPH Chemie + Papier Holding.

The company operates three plants in Germany, Switzerland and the US, where it produces films ranging from mono-PVC to ultra-high-PVdC coated films for blister packaging.

Perlen Packaging sales and marketing director Johannes Giessler said: "The pharma markets in Europe are continually growing and the demand for barrier films is increasing.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

"Thanks to the continuous investments in our technology and our GMP standard production facilities in Germany and Switzerland, we can ensure the continued availability of our high-quality products for the European pharmaceutical market."

Image: Perlen Packaging coating line in Switzerland. Photo: courtesy of Perlen Packaging.